Martindale Pharma

Leading niche manufacturer and supplier of specialty pharmaceutical products

Business activity and description

Based in Romford, UK, Martindale Pharma (‘Martindale’) is a leading niche manufacturer and supplier of specialty pharmaceutical products and services, including Unlicensed medicines (‘Specials’), injectables, pre-filled syringes and oral solutions. Martindale has a diverse portfolio of over 200 licensed compounds and a proprietary database of 30,000 formulations for Specials. Martindale’s in-house expertise covers the full product lifecycle from formulation, to product development, registration and licensing, manufacturing and full quality monitoring and testing.

Deal Information

• Deal size: Undisclosed
• Deal type: MBO
• Turnover: GBP 65 mln
• Date of investment: May 2010
• Bought from: Cardinal Health Inc

Investment rationale

Martindale has a strong and well-diversified portfolio of niche pharmaceutical products, including leading positions in the growing Specials and Addiction markets. Martindale has well-developed barriers to entry, through a combination of high market share positions in specialist areas, regulatory protection and strong interrelationships with key customers. AAC Capital Partners plans to continue to develop the business and pursue growth opportunities across the portfolio.